We are live on
!
Find out more
HA
Hays Advisory Portfolio holdings
AUM
$157M
1-Year Est. Return
9.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.33%
1 Year Est. Return
+9.67%
3 Year Est. Return
+31.82%
5 Year Est. Return
+56.04%
10 Year Est. Return
–
AUM
$589M
AUM Growth
-$72M
(-11%)
Cap. Flow
-$61.7M
Cap. Flow
% of AUM
-10.47%
Top 10 Holdings %
Top 10 Hldgs %
49.94%
Holding
74
New
7
Increased
14
Reduced
39
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Financials AlphaDEX Fund
FXO
|
+$23.3M |
| 2 |
Visteon
VC
|
+$9.4M |
| 3 |
MDP
Meredith Corporation
MDP
|
+$9.04M |
| 4 |
Argan
AGX
|
+$8.21M |
| 5 |
Wabash National
WNC
|
+$8.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$25M |
| 2 |
CVS Health
CVS
|
+$16.5M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$12.3M |
| 4 |
CF Industries
CF
|
+$9.25M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$8.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.13% |
| 2 | Industrials | 9.16% |
| 3 | Healthcare | 9.1% |
| 4 | Consumer Discretionary | 6.57% |
| 5 | Consumer Staples | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Argan
AGX
$7.98B
| $8.26M | 1.4% |
254,816
+228,212
| +858% | +$8.21M |
|
|
27
Wabash National
WNC
$543M
| $8.14M | 1.38% |
+687,983
| New | +$8.13M |
|
|
VIAB
28
DELISTED
Viacom Inc. Class B
VIAB
| $8.13M | 1.38% |
197,589
-22,409
| -10% | -$1.05M |
|
29
Apple
AAPL
$4.89T
| $7.96M | 1.35% |
302,548
-28,960
| -9% | -$828K |
|
|
STRZA
30
DELISTED
Starz - Series A
STRZA
| $7.87M | 1.34% |
234,938
-23,843
| -9% | -$850K |
|
31
Pilgrim's Pride
PPC
$6.82B
| $7.34M | 1.25% |
332,460
-42,351
| -11% | -$867K |
|
32
Enanta Pharmaceuticals
ENTA
$372M
| $7.24M | 1.23% |
219,098
-28,758
| -12% | -$937K |
|
|
BRCD
33
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $6.96M | 1.18% |
757,744
-109,616
| -13% | -$1.08M |
|
34
American Express
AXP
$223B
| $6.92M | 1.17% |
99,442
-13,659
| -12% | -$994K |
|
35
Best Buy
BBY
$18B
| $6.91M | 1.17% |
226,776
-33,259
| -13% | -$1.1M |
|
36
Cal-Maine
CALM
$4.28B
| $6.77M | 1.15% |
+146,140
| New | +$7.87M |
|
|
RPXC
37
DELISTED
RPX Corporation
RPXC
| $6.56M | 1.11% |
+595,957
| New | +$8.07M |
|
38
GameStop
GME
$9.5B
| $5.81M | 0.99% |
828,760
-105,948
| -11% | -$1.02M |
|
|
OUTR
39
DELISTED
OUTERWALL INC
OUTR
| $5.18M | 0.88% |
141,739
-18,137
| -11% | -$1.01M |
|
40
Buckle
BKE
$2.19B
| $4.49M | 0.76% |
145,944
-17,080
| -10% | -$567K |
|
41
Vanguard Total Stock Market ETF
VTI
$654B
| $4.46M | 0.76% |
42,806
+32,543
| +317% | +$3.43M |
|
|
NSR
42
DELISTED
Neustar Inc
NSR
| $4.23M | 0.72% |
176,316
-25,582
| -13% | -$661K |
|
|
LUMO
43
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $3.78M | 0.64% |
11,547
-1,249
| -10% | -$407K |
|
44
Nu Skin
NUS
$247M
| $3.59M | 0.61% |
94,794
-9,656
| -9% | -$356K |
|
45
HP
HPQ
$23.5B
| $3.49M | 0.59% |
294,794
-427,590
| -59% | -$5.47M |
|
|
LCI
46
DELISTED
Lannett Company, Inc.
LCI
| $3.45M | 0.59% |
21,486
-2,499
| -10% | -$410K |
|
|
PDLI
47
DELISTED
PDL BioPharma, Inc.
PDLI
| $3.14M | 0.53% |
887,214
-144,326
| -14% | -$604K |
|
48
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $2.73M | 0.46% |
40,884
+1,198
| +3% | +$80.4K |
|
49
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $2.54M | 0.43% |
52,534
+6,545
| +14% | +$316K |
|
|
ICON
50
DELISTED
Iconix Brand Group, Inc.
ICON
| $2.44M | 0.41% |
35,788
-5,673
| -14% | -$582K |
|
Similar funds
PAM
KC
CAS
MCM
FIM
ACM
ACM
TCM
Hays Advisory's Q4 2015 Portfolio in Review
As of Q4 2015, Hays Advisory held 74 positions worth $589M, down 11% from $661M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Hays Advisory withdrew a net $61.7M in Q4 2015, closing 11 positions and reducing 39 holdings. Its most notable exit was CVS Health, an estimated $16.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Hays Advisory opened a new position in First Trust Financials AlphaDEX Fund worth $22.9M.
- Hays Advisory's largest Q4 2015 buy was First Trust Financials AlphaDEX Fund: 987,487 shares worth $22.9M.
- Hays Advisory added most to Argan in Q4 2015, an estimated $8.21M increase.
- Hays Advisory's biggest Q4 2015 reduction was First Trust Health Care AlphaDEX Fund, cutting an estimated $25M.
- Hays Advisory fully exited CVS Health in Q4 2015, selling an estimated $16.5M.
- Hays Advisory's ten largest holdings make up 50% of its $589M portfolio in Q4 2015.
- Hays Advisory opened 7 new positions and closed 11 in Q4 2015.
- Hays Advisory's portfolio value fell 11% quarter-over-quarter to $589M.
Based on Hays Advisory's 13F filing for Q4 2015, filed 12 Jan 2016.